GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000003 | Reproduction |
| Process | GO:0000122 | Negative regulation of transcription by RNA polymerase II |
| Process | GO:0000902 | Cell morphogenesis |
| Process | GO:0000904 | Cell morphogenesis involved in differentiation |
| Process | GO:0001501 | Skeletal system development |
| Process | GO:0001525 | Angiogenesis |
| Process | GO:0001568 | Blood vessel development |
| Process | GO:0001570 | Vasculogenesis |
| Process | GO:0001654 | Eye development |
| Process | GO:0001655 | Urogenital system development |
| Process | GO:0001666 | Response to hypoxia |
| Process | GO:0001701 | In utero embryonic development |
| Process | GO:0001708 | Cell fate specification |
| Process | GO:0001754 | Eye photoreceptor cell differentiation |
| Process | GO:0001763 | Morphogenesis of a branching structure |
| Process | GO:0001822 | Kidney development |
| Process | GO:0001837 | Epithelial to mesenchymal transition |
| Process | GO:0001889 | Liver development |
| Process | GO:0001894 | Tissue homeostasis |
| Process | GO:0001942 | Hair follicle development |
| Process | GO:0001944 | Vasculature development |
| Process | GO:0001947 | Heart looping |
| Process | GO:0002009 | Morphogenesis of an epithelium |
| Process | GO:0002011 | Morphogenesis of an epithelial sheet |
| Process | GO:0002040 | Sprouting angiogenesis |
| Process | GO:0002052 | Positive regulation of neuroblast proliferation |
| Process | GO:0002064 | Epithelial cell development |
| Process | GO:0002065 | Columnar/cuboidal epithelial cell differentiation |
| Process | GO:0002067 | Glandular epithelial cell differentiation |
| Process | GO:0002085 | Inhibition of neuroepithelial cell differentiation |
| Process | GO:0002237 | Response to molecule of bacterial origin |
| Process | GO:0002250 | Adaptive immune response |
| Process | GO:0002347 | Response to tumor cell |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002437 | Inflammatory response to antigenic stimulus |
| Process | GO:0002460 | Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| Process | GO:0003002 | Regionalization |
| Process | GO:0003006 | Developmental process involved in reproduction |
| Process | GO:0003007 | Heart morphogenesis |
| Process | GO:0003143 | Embryonic heart tube morphogenesis |
| Process | GO:0003151 | Outflow tract morphogenesis |
| Process | GO:0003157 | Endocardium development |
| Process | GO:0003158 | Endothelium development |
| Process | GO:0003160 | Endocardium morphogenesis |
| Process | GO:0003161 | Cardiac conduction system development |
| Process | GO:0003162 | Atrioventricular node development |
| Process | GO:0003169 | Coronary vein morphogenesis |
| Process | GO:0003170 | Heart valve development |
| Process | GO:0003171 | Atrioventricular valve development |
| Process | GO:0003174 | Mitral valve development |
| Process | GO:0003176 | Aortic valve development |
| Process | GO:0003177 | Pulmonary valve development |
| Process | GO:0003178 | Coronary sinus valve development |
| Process | GO:0003179 | Heart valve morphogenesis |
| Process | GO:0003180 | Aortic valve morphogenesis |
| Process | GO:0003181 | Atrioventricular valve morphogenesis |
| Process | GO:0003182 | Coronary sinus valve morphogenesis |
| Process | GO:0003183 | Mitral valve morphogenesis |
| Process | GO:0003184 | Pulmonary valve morphogenesis |
| Process | GO:0003188 | Heart valve formation |
| Process | GO:0003190 | Atrioventricular valve formation |
| Process | GO:0003192 | Mitral valve formation |
| Process | GO:0003197 | Endocardial cushion development |
| Process | GO:0003198 | Epithelial to mesenchymal transition involved in endocardial cushion formation |
| Process | GO:0003203 | Endocardial cushion morphogenesis |
| Process | GO:0003205 | Cardiac chamber development |
| Process | GO:0003206 | Cardiac chamber morphogenesis |
| Process | GO:0003207 | Cardiac chamber formation |
| Process | GO:0003208 | Cardiac ventricle morphogenesis |
| Process | GO:0003209 | Cardiac atrium morphogenesis |
| Process | GO:0003211 | Cardiac ventricle formation |
| Process | GO:0003213 | Cardiac right atrium morphogenesis |
| Process | GO:0003214 | Cardiac left ventricle morphogenesis |
| Process | GO:0003215 | Cardiac right ventricle morphogenesis |
| Process | GO:0003219 | Cardiac right ventricle formation |
| Process | GO:0003222 | Ventricular trabecula myocardium morphogenesis |
| Process | GO:0003229 | Ventricular cardiac muscle tissue development |
| Process | GO:0003230 | Cardiac atrium development |
| Process | GO:0003231 | Cardiac ventricle development |
| Process | GO:0003241 | Growth involved in heart morphogenesis |
| Process | GO:0003250 | Regulation of cell proliferation involved in heart valve morphogenesis |
| Process | GO:0003252 | Negative regulation of cell proliferation involved in heart valve morphogenesis |
| Process | GO:0003264 | Regulation of cardioblast proliferation |
| Process | GO:0003266 | Regulation of secondary heart field cardioblast proliferation |
| Process | GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation |
| Process | GO:0003272 | Endocardial cushion formation |
| Process | GO:0003273 | Cell migration involved in endocardial cushion formation |
| Process | GO:0003279 | Cardiac septum development |
| Process | GO:0003281 | Ventricular septum development |
| Process | GO:0003330 | Regulation of extracellular matrix constituent secretion |
| Process | GO:0003332 | Negative regulation of extracellular matrix constituent secretion |
| Process | GO:0003344 | Pericardium morphogenesis |
| Process | GO:0003348 | Cardiac endothelial cell differentiation |
| Process | GO:0003407 | Neural retina development |
| Process | GO:0006139 | Nucleobase-containing compound metabolic process |
| Process | GO:0006351 | Transcription, DNA-templated |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006357 | Regulation of transcription by RNA polymerase II |
| Process | GO:0006366 | Transcription by RNA polymerase II |
| Process | GO:0006606 | Protein import into nucleus |
| Process | GO:0006725 | Cellular aromatic compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006810 | Transport |
| Process | GO:0006886 | Intracellular protein transport |
| Process | GO:0006887 | Exocytosis |
| Process | GO:0006913 | Nucleocytoplasmic transport |
| Process | GO:0006915 | Apoptotic process |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006952 | Defense response |
| Process | GO:0006954 | Inflammatory response |
| Process | GO:0006955 | Immune response |
| Process | GO:0006959 | Humoral immune response |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007162 | Negative regulation of cell adhesion |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007166 | Cell surface receptor signaling pathway |
| Process | GO:0007219 | Notch signaling pathway |
| Process | GO:0007221 | Positive regulation of transcription of Notch receptor target |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007276 | Gamete generation |
| Process | GO:0007283 | Spermatogenesis |
| Process | GO:0007368 | Determination of left/right symmetry |
| Process | GO:0007386 | Compartment pattern specification |
| Process | GO:0007389 | Pattern specification process |
| Process | GO:0007399 | Nervous system development |
| Process | GO:0007409 | Axonogenesis |
| Process | GO:0007417 | Central nervous system development |
| Process | GO:0007420 | Brain development |
| Process | GO:0007423 | Sensory organ development |
| Process | GO:0007440 | Foregut morphogenesis |
| Process | GO:0007492 | Endoderm development |
| Process | GO:0007507 | Heart development |
| Process | GO:0007517 | Muscle organ development |
| Process | GO:0007519 | Skeletal muscle tissue development |
| Process | GO:0008104 | Protein localization |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008219 | Cell death |
| Process | GO:0008283 | Cell population proliferation |
| Process | GO:0008284 | Positive regulation of cell population proliferation |
| Process | GO:0008285 | Negative regulation of cell population proliferation |
| Process | GO:0008544 | Epidermis development |
| Process | GO:0008593 | Regulation of Notch signaling pathway |
| Process | GO:0009056 | Catabolic process |
| Process | GO:0009057 | Macromolecule catabolic process |
| Process | GO:0009058 | Biosynthetic process |
| Process | GO:0009059 | Macromolecule biosynthetic process |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009617 | Response to bacterium |
| Process | GO:0009628 | Response to abiotic stimulus |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009719 | Response to endogenous stimulus |
| Process | GO:0009725 | Response to hormone |
| Process | GO:0009790 | Embryo development |
| Process | GO:0009792 | Embryo development ending in birth or egg hatching |
| Process | GO:0009798 | Axis specification |
| Process | GO:0009799 | Specification of symmetry |
| Process | GO:0009855 | Determination of bilateral symmetry |
| Process | GO:0009887 | Animal organ morphogenesis |
| Process | GO:0009888 | Tissue development |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009890 | Negative regulation of biosynthetic process |
| Process | GO:0009891 | Positive regulation of biosynthetic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009912 | Auditory receptor cell fate commitment |
| Process | GO:0009913 | Epidermal cell differentiation |
| Process | GO:0009952 | Anterior/posterior pattern specification |
| Process | GO:0009957 | Epidermal cell fate specification |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009967 | Positive regulation of signal transduction |
| Process | GO:0009968 | Negative regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010001 | Glial cell differentiation |
| Process | GO:0010002 | Cardioblast differentiation |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010243 | Response to organonitrogen compound |
| Process | GO:0010467 | Gene expression |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010557 | Positive regulation of macromolecule biosynthetic process |
| Process | GO:0010558 | Negative regulation of macromolecule biosynthetic process |
| Process | GO:0010594 | Regulation of endothelial cell migration |
| Process | GO:0010596 | Negative regulation of endothelial cell migration |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010605 | Negative regulation of macromolecule metabolic process |
| Process | GO:0010611 | Regulation of cardiac muscle hypertrophy |
| Process | GO:0010614 | Negative regulation of cardiac muscle hypertrophy |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0010629 | Negative regulation of gene expression |
| Process | GO:0010632 | Regulation of epithelial cell migration |
| Process | GO:0010633 | Negative regulation of epithelial cell migration |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010648 | Negative regulation of cell communication |
| Process | GO:0010717 | Regulation of epithelial to mesenchymal transition |
| Process | GO:0010718 | Positive regulation of epithelial to mesenchymal transition |
| Process | GO:0010720 | Positive regulation of cell development |
| Process | GO:0010721 | Negative regulation of cell development |
| Process | GO:0010810 | Regulation of cell-substrate adhesion |
| Process | GO:0010812 | Negative regulation of cell-substrate adhesion |
| Process | GO:0010830 | Regulation of myotube differentiation |
| Process | GO:0010832 | Negative regulation of myotube differentiation |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0010942 | Positive regulation of cell death |
| Process | GO:0012501 | Programmed cell death |
| Process | GO:0014013 | Regulation of gliogenesis |
| Process | GO:0014014 | Negative regulation of gliogenesis |
| Process | GO:0014015 | Positive regulation of gliogenesis |
| Process | GO:0014031 | Mesenchymal cell development |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0014706 | Striated muscle tissue development |
| Process | GO:0014741 | Negative regulation of muscle hypertrophy |
| Process | GO:0014743 | Regulation of muscle hypertrophy |
| Process | GO:0014807 | Regulation of somitogenesis |
| Process | GO:0014855 | Striated muscle cell proliferation |
| Process | GO:0015031 | Protein transport |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016070 | RNA metabolic process |
| Process | GO:0016192 | Vesicle-mediated transport |
| Process | GO:0016477 | Cell migration |
| Process | GO:0017145 | Stem cell division |
| Process | GO:0017156 | Calcium-ion regulated exocytosis |
| Process | GO:0017157 | Regulation of exocytosis |
| Process | GO:0017158 | Regulation of calcium ion-dependent exocytosis |
| Process | GO:0018130 | Heterocycle biosynthetic process |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019221 | Cytokine-mediated signaling pathway |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019438 | Aromatic compound biosynthetic process |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0019827 | Stem cell population maintenance |
| Process | GO:0019953 | Sexual reproduction |
| Process | GO:0021510 | Spinal cord development |
| Process | GO:0021515 | Cell differentiation in spinal cord |
| Process | GO:0021915 | Neural tube development |
| Process | GO:0022008 | Neurogenesis |
| Process | GO:0022404 | Molting cycle process |
| Process | GO:0022405 | Hair cycle process |
| Process | GO:0022407 | Regulation of cell-cell adhesion |
| Process | GO:0022408 | Negative regulation of cell-cell adhesion |
| Process | GO:0022414 | Reproductive process |
| Process | GO:0022603 | Regulation of anatomical structure morphogenesis |
| Process | GO:0022607 | Cellular component assembly |
| Process | GO:0022612 | Gland morphogenesis |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023052 | Signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0023057 | Negative regulation of signaling |
| Process | GO:0030030 | Cell projection organization |
| Process | GO:0030031 | Cell projection assembly |
| Process | GO:0030111 | Regulation of Wnt signaling pathway |
| Process | GO:0030154 | Cell differentiation |
| Process | GO:0030155 | Regulation of cell adhesion |
| Process | GO:0030163 | Protein catabolic process |
| Process | GO:0030178 | Negative regulation of Wnt signaling pathway |
| Process | GO:0030182 | Neuron differentiation |
| Process | GO:0030216 | Keratinocyte differentiation |
| Process | GO:0030278 | Regulation of ossification |
| Process | GO:0030279 | Negative regulation of ossification |
| Process | GO:0030323 | Respiratory tube development |
| Process | GO:0030324 | Lung development |
| Process | GO:0030326 | Embryonic limb morphogenesis |
| Process | GO:0030334 | Regulation of cell migration |
| Process | GO:0030335 | Positive regulation of cell migration |
| Process | GO:0030336 | Negative regulation of cell migration |
| Process | GO:0030510 | Regulation of BMP signaling pathway |
| Process | GO:0030513 | Positive regulation of BMP signaling pathway |
| Process | GO:0030514 | Negative regulation of BMP signaling pathway |
| Process | GO:0030850 | Prostate gland development |
| Process | GO:0030855 | Epithelial cell differentiation |
| Process | GO:0030856 | Regulation of epithelial cell differentiation |
| Process | GO:0030857 | Negative regulation of epithelial cell differentiation |
| Process | GO:0030858 | Positive regulation of epithelial cell differentiation |
| Process | GO:0030900 | Forebrain development |
| Process | GO:0031069 | Hair follicle morphogenesis |
| Process | GO:0031099 | Regeneration |
| Process | GO:0031100 | Animal organ regeneration |
| Process | GO:0031175 | Neuron projection development |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031324 | Negative regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031327 | Negative regulation of cellular biosynthetic process |
| Process | GO:0031328 | Positive regulation of cellular biosynthetic process |
| Process | GO:0031960 | Response to corticosteroid |
| Process | GO:0032101 | Regulation of response to external stimulus |
| Process | GO:0032102 | Negative regulation of response to external stimulus |
| Process | GO:0032354 | Response to follicle-stimulating hormone |
| Process | GO:0032495 | Response to muramyl dipeptide |
| Process | GO:0032496 | Response to lipopolysaccharide |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032504 | Multicellular organism reproduction |
| Process | GO:0032774 | RNA biosynthetic process |
| Process | GO:0032835 | Glomerulus development |
| Process | GO:0032870 | Cellular response to hormone stimulus |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032940 | Secretion by cell |
| Process | GO:0032989 | Cellular component morphogenesis |
| Process | GO:0032990 | Cell part morphogenesis |
| Process | GO:0033002 | Muscle cell proliferation |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033365 | Protein localization to organelle |
| Process | GO:0033554 | Cellular response to stress |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0034097 | Response to cytokine |
| Process | GO:0034504 | Protein localization to nucleus |
| Process | GO:0034641 | Cellular nitrogen compound metabolic process |
| Process | GO:0034654 | Nucleobase-containing compound biosynthetic process |
| Process | GO:0034698 | Response to gonadotropin |
| Process | GO:0035050 | Embryonic heart tube development |
| Process | GO:0035051 | Cardiocyte differentiation |
| Process | GO:0035107 | Appendage morphogenesis |
| Process | GO:0035108 | Limb morphogenesis |
| Process | GO:0035113 | Embryonic appendage morphogenesis |
| Process | GO:0035116 | Embryonic hindlimb morphogenesis |
| Process | GO:0035137 | Hindlimb morphogenesis |
| Process | GO:0035148 | Tube formation |
| Process | GO:0035239 | Tube morphogenesis |
| Process | GO:0035265 | Organ growth |
| Process | GO:0035295 | Tube development |
| Process | GO:0035315 | Hair cell differentiation |
| Process | GO:0035850 | Epithelial cell differentiation involved in kidney development |
| Process | GO:0035886 | Vascular associated smooth muscle cell differentiation |
| Process | GO:0035914 | Skeletal muscle cell differentiation |
| Process | GO:0035924 | Cellular response to vascular endothelial growth factor stimulus |
| Process | GO:0036003 | Positive regulation of transcription from RNA polymerase II promoter in response to stress |
| Process | GO:0036293 | Response to decreased oxygen levels |
| Process | GO:0036294 | Cellular response to decreased oxygen levels |
| Process | GO:0040007 | Growth |
| Process | GO:0040008 | Regulation of growth |
| Process | GO:0040012 | Regulation of locomotion |
| Process | GO:0040013 | Negative regulation of locomotion |
| Process | GO:0040017 | Positive regulation of locomotion |
| Process | GO:0040034 | Regulation of development, heterochronic |
| Process | GO:0042063 | Gliogenesis |
| Process | GO:0042127 | Regulation of cell population proliferation |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042246 | Tissue regeneration |
| Process | GO:0042303 | Molting cycle |
| Process | GO:0042490 | Mechanoreceptor differentiation |
| Process | GO:0042491 | Inner ear auditory receptor cell differentiation |
| Process | GO:0042592 | Homeostatic process |
| Process | GO:0042633 | Hair cycle |
| Process | GO:0042670 | Retinal cone cell differentiation |
| Process | GO:0042692 | Muscle cell differentiation |
| Process | GO:0042733 | Embryonic digit morphogenesis |
| Process | GO:0042981 | Regulation of apoptotic process |
| Process | GO:0043009 | Chordate embryonic development |
| Process | GO:0043010 | Camera-type eye development |
| Process | GO:0043065 | Positive regulation of apoptotic process |
| Process | GO:0043066 | Negative regulation of apoptotic process |
| Process | GO:0043067 | Regulation of programmed cell death |
| Process | GO:0043068 | Positive regulation of programmed cell death |
| Process | GO:0043069 | Negative regulation of programmed cell death |
| Process | GO:0043086 | Negative regulation of catalytic activity |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0043408 | Regulation of MAPK cascade |
| Process | GO:0043410 | Positive regulation of MAPK cascade |
| Process | GO:0043502 | Regulation of muscle adaptation |
| Process | GO:0043535 | Regulation of blood vessel endothelial cell migration |
| Process | GO:0043537 | Negative regulation of blood vessel endothelial cell migration |
| Process | GO:0043583 | Ear development |
| Process | GO:0043588 | Skin development |
| Process | GO:0043618 | Regulation of transcription from RNA polymerase II promoter in response to stress |
| Process | GO:0043620 | Regulation of DNA-templated transcription in response to stress |
| Process | GO:0044057 | Regulation of system process |
| Process | GO:0044085 | Cellular component biogenesis |
| Process | GO:0044087 | Regulation of cellular component biogenesis |
| Process | GO:0044092 | Negative regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044249 | Cellular biosynthetic process |
| Process | GO:0044271 | Cellular nitrogen compound biosynthetic process |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0044782 | Cilium organization |
| Process | GO:0045055 | Regulated exocytosis |
| Process | GO:0045069 | Regulation of viral genome replication |
| Process | GO:0045070 | Positive regulation of viral genome replication |
| Process | GO:0045165 | Cell fate commitment |
| Process | GO:0045184 | Establishment of protein localization |
| Process | GO:0045445 | Myoblast differentiation |
| Process | GO:0045446 | Endothelial cell differentiation |
| Process | GO:0045595 | Regulation of cell differentiation |
| Process | GO:0045596 | Negative regulation of cell differentiation |
| Process | GO:0045597 | Positive regulation of cell differentiation |
| Process | GO:0045601 | Regulation of endothelial cell differentiation |
| Process | GO:0045603 | Positive regulation of endothelial cell differentiation |
| Process | GO:0045604 | Regulation of epidermal cell differentiation |
| Process | GO:0045605 | Negative regulation of epidermal cell differentiation |
| Process | GO:0045606 | Positive regulation of epidermal cell differentiation |
| Process | GO:0045607 | Regulation of inner ear auditory receptor cell differentiation |
| Process | GO:0045608 | Negative regulation of inner ear auditory receptor cell differentiation |
| Process | GO:0045616 | Regulation of keratinocyte differentiation |
| Process | GO:0045618 | Positive regulation of keratinocyte differentiation |
| Process | GO:0045631 | Regulation of mechanoreceptor differentiation |
| Process | GO:0045632 | Negative regulation of mechanoreceptor differentiation |
| Process | GO:0045661 | Regulation of myoblast differentiation |
| Process | GO:0045662 | Negative regulation of myoblast differentiation |
| Process | GO:0045664 | Regulation of neuron differentiation |
| Process | GO:0045665 | Negative regulation of neuron differentiation |
| Process | GO:0045667 | Regulation of osteoblast differentiation |
| Process | GO:0045668 | Negative regulation of osteoblast differentiation |
| Process | GO:0045682 | Regulation of epidermis development |
| Process | GO:0045683 | Negative regulation of epidermis development |
| Process | GO:0045684 | Positive regulation of epidermis development |
| Process | GO:0045685 | Regulation of glial cell differentiation |
| Process | GO:0045686 | Negative regulation of glial cell differentiation |
| Process | GO:0045687 | Positive regulation of glial cell differentiation |
| Process | GO:0045747 | Positive regulation of Notch signaling pathway |
| Process | GO:0045892 | Negative regulation of transcription, DNA-templated |
| Process | GO:0045893 | Positive regulation of transcription, DNA-templated |
| Process | GO:0045920 | Negative regulation of exocytosis |
| Process | GO:0045927 | Positive regulation of growth |
| Process | GO:0045934 | Negative regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045935 | Positive regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045944 | Positive regulation of transcription by RNA polymerase II |
| Process | GO:0045955 | Negative regulation of calcium ion-dependent exocytosis |
| Process | GO:0045995 | Regulation of embryonic development |
| Process | GO:0046425 | Regulation of receptor signaling pathway via JAK-STAT |
| Process | GO:0046427 | Positive regulation of receptor signaling pathway via JAK-STAT |
| Process | GO:0046483 | Heterocycle metabolic process |
| Process | GO:0046530 | Photoreceptor cell differentiation |
| Process | GO:0046532 | Regulation of photoreceptor cell differentiation |
| Process | GO:0046533 | Negative regulation of photoreceptor cell differentiation |
| Process | GO:0046578 | Regulation of Ras protein signal transduction |
| Process | GO:0046579 | Positive regulation of Ras protein signal transduction |
| Process | GO:0046620 | Regulation of organ growth |
| Process | GO:0046622 | Positive regulation of organ growth |
| Process | GO:0046782 | Regulation of viral transcription |
| Process | GO:0046903 | Secretion |
| Process | GO:0046907 | Intracellular transport |
| Process | GO:0048103 | Somatic stem cell division |
| Process | GO:0048232 | Male gamete generation |
| Process | GO:0048468 | Cell development |
| Process | GO:0048505 | Regulation of timing of cell differentiation |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048514 | Blood vessel morphogenesis |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048524 | Positive regulation of viral process |
| Process | GO:0048545 | Response to steroid hormone |
| Process | GO:0048546 | Digestive tract morphogenesis |
| Process | GO:0048562 | Embryonic organ morphogenesis |
| Process | GO:0048565 | Digestive tract development |
| Process | GO:0048568 | Embryonic organ development |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0048585 | Negative regulation of response to stimulus |
| Process | GO:0048589 | Developmental growth |
| Process | GO:0048592 | Eye morphogenesis |
| Process | GO:0048593 | Camera-type eye morphogenesis |
| Process | GO:0048598 | Embryonic morphogenesis |
| Process | GO:0048608 | Reproductive structure development |
| Process | GO:0048609 | Multicellular organismal reproductive process |
| Process | GO:0048638 | Regulation of developmental growth |
| Process | GO:0048639 | Positive regulation of developmental growth |
| Process | GO:0048644 | Muscle organ morphogenesis |
| Process | GO:0048646 | Anatomical structure formation involved in morphogenesis |
| Process | GO:0048663 | Neuron fate commitment |
| Process | GO:0048666 | Neuron development |
| Process | GO:0048667 | Cell morphogenesis involved in neuron differentiation |
| Process | GO:0048699 | Generation of neurons |
| Process | GO:0048708 | Astrocyte differentiation |
| Process | GO:0048709 | Oligodendrocyte differentiation |
| Process | GO:0048710 | Regulation of astrocyte differentiation |
| Process | GO:0048711 | Positive regulation of astrocyte differentiation |
| Process | GO:0048713 | Regulation of oligodendrocyte differentiation |
| Process | GO:0048715 | Negative regulation of oligodendrocyte differentiation |
| Process | GO:0048729 | Tissue morphogenesis |
| Process | GO:0048730 | Epidermis morphogenesis |
| Process | GO:0048731 | System development |
| Process | GO:0048732 | Gland development |
| Process | GO:0048736 | Appendage development |
| Process | GO:0048738 | Cardiac muscle tissue development |
| Process | GO:0048754 | Branching morphogenesis of an epithelial tube |
| Process | GO:0048762 | Mesenchymal cell differentiation |
| Process | GO:0048812 | Neuron projection morphogenesis |
| Process | GO:0048839 | Inner ear development |
| Process | GO:0048844 | Artery morphogenesis |
| Process | GO:0048845 | Venous blood vessel morphogenesis |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048858 | Cell projection morphogenesis |
| Process | GO:0048863 | Stem cell differentiation |
| Process | GO:0048869 | Cellular developmental process |
| Process | GO:0048870 | Cell motility |
| Process | GO:0048871 | Multicellular organismal homeostasis |
| Process | GO:0048872 | Homeostasis of number of cells |
| Process | GO:0048873 | Homeostasis of number of cells within a tissue |
| Process | GO:0048880 | Sensory system development |
| Process | GO:0050434 | Positive regulation of viral transcription |
| Process | GO:0050673 | Epithelial cell proliferation |
| Process | GO:0050678 | Regulation of epithelial cell proliferation |
| Process | GO:0050679 | Positive regulation of epithelial cell proliferation |
| Process | GO:0050680 | Negative regulation of epithelial cell proliferation |
| Process | GO:0050767 | Regulation of neurogenesis |
| Process | GO:0050768 | Negative regulation of neurogenesis |
| Process | GO:0050769 | Positive regulation of neurogenesis |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050792 | Regulation of viral process |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0050920 | Regulation of chemotaxis |
| Process | GO:0050922 | Negative regulation of chemotaxis |
| Process | GO:0051046 | Regulation of secretion |
| Process | GO:0051048 | Negative regulation of secretion |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051051 | Negative regulation of transport |
| Process | GO:0051056 | Regulation of small GTPase mediated signal transduction |
| Process | GO:0051057 | Positive regulation of small GTPase mediated signal transduction |
| Process | GO:0051093 | Negative regulation of developmental process |
| Process | GO:0051094 | Positive regulation of developmental process |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051129 | Negative regulation of cellular component organization |
| Process | GO:0051145 | Smooth muscle cell differentiation |
| Process | GO:0051147 | Regulation of muscle cell differentiation |
| Process | GO:0051148 | Negative regulation of muscle cell differentiation |
| Process | GO:0051153 | Regulation of striated muscle cell differentiation |
| Process | GO:0051154 | Negative regulation of striated muscle cell differentiation |
| Process | GO:0051169 | Nuclear transport |
| Process | GO:0051170 | Import into nucleus |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051172 | Negative regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051241 | Negative regulation of multicellular organismal process |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051253 | Negative regulation of RNA metabolic process |
| Process | GO:0051254 | Positive regulation of RNA metabolic process |
| Process | GO:0051301 | Cell division |
| Process | GO:0051641 | Cellular localization |
| Process | GO:0051649 | Establishment of localization in cell |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051960 | Regulation of nervous system development |
| Process | GO:0051961 | Negative regulation of nervous system development |
| Process | GO:0051962 | Positive regulation of nervous system development |
| Process | GO:0055001 | Muscle cell development |
| Process | GO:0055006 | Cardiac cell development |
| Process | GO:0055008 | Cardiac muscle tissue morphogenesis |
| Process | GO:0055010 | Ventricular cardiac muscle tissue morphogenesis |
| Process | GO:0055017 | Cardiac muscle tissue growth |
| Process | GO:0055021 | Regulation of cardiac muscle tissue growth |
| Process | GO:0055023 | Positive regulation of cardiac muscle tissue growth |
| Process | GO:0055123 | Digestive system development |
| Process | GO:0060038 | Cardiac muscle cell proliferation |
| Process | GO:0060039 | Pericardium development |
| Process | GO:0060041 | Retina development in camera-type eye |
| Process | GO:0060042 | Retina morphogenesis in camera-type eye |
| Process | GO:0060043 | Regulation of cardiac muscle cell proliferation |
| Process | GO:0060045 | Positive regulation of cardiac muscle cell proliferation |
| Process | GO:0060113 | Inner ear receptor cell differentiation |
| Process | GO:0060120 | Inner ear receptor cell fate commitment |
| Process | GO:0060173 | Limb development |
| Process | GO:0060219 | Camera-type eye photoreceptor cell differentiation |
| Process | GO:0060249 | Anatomical structure homeostasis |
| Process | GO:0060251 | Regulation of glial cell proliferation |
| Process | GO:0060253 | Negative regulation of glial cell proliferation |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060271 | Cilium assembly |
| Process | GO:0060284 | Regulation of cell development |
| Process | GO:0060317 | Cardiac epithelial to mesenchymal transition |
| Process | GO:0060322 | Head development |
| Process | GO:0060353 | Regulation of cell adhesion molecule production |
| Process | GO:0060354 | Negative regulation of cell adhesion molecule production |
| Process | GO:0060379 | Cardiac muscle cell myoblast differentiation |
| Process | GO:0060411 | Cardiac septum morphogenesis |
| Process | GO:0060412 | Ventricular septum morphogenesis |
| Process | GO:0060415 | Muscle tissue morphogenesis |
| Process | GO:0060419 | Heart growth |
| Process | GO:0060420 | Regulation of heart growth |
| Process | GO:0060421 | Positive regulation of heart growth |
| Process | GO:0060429 | Epithelium development |
| Process | GO:0060485 | Mesenchyme development |
| Process | GO:0060512 | Prostate gland morphogenesis |
| Process | GO:0060525 | Prostate glandular acinus development |
| Process | GO:0060528 | Secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development |
| Process | GO:0060537 | Muscle tissue development |
| Process | GO:0060538 | Skeletal muscle organ development |
| Process | GO:0060541 | Respiratory system development |
| Process | GO:0060548 | Negative regulation of cell death |
| Process | GO:0060560 | Developmental growth involved in morphogenesis |
| Process | GO:0060561 | Apoptotic process involved in morphogenesis |
| Process | GO:0060562 | Epithelial tube morphogenesis |
| Process | GO:0060563 | Neuroepithelial cell differentiation |
| Process | GO:0060627 | Regulation of vesicle-mediated transport |
| Process | GO:0060740 | Prostate gland epithelium morphogenesis |
| Process | GO:0060742 | Epithelial cell differentiation involved in prostate gland development |
| Process | GO:0060768 | Regulation of epithelial cell proliferation involved in prostate gland development |
| Process | GO:0060828 | Regulation of canonical Wnt signaling pathway |
| Process | GO:0060837 | Blood vessel endothelial cell differentiation |
| Process | GO:0060840 | Artery development |
| Process | GO:0060841 | Venous blood vessel development |
| Process | GO:0060842 | Arterial endothelial cell differentiation |
| Process | GO:0060843 | Venous endothelial cell differentiation |
| Process | GO:0060947 | Cardiac vascular smooth muscle cell differentiation |
| Process | GO:0060948 | Cardiac vascular smooth muscle cell development |
| Process | GO:0060956 | Endocardial cell differentiation |
| Process | GO:0060972 | Left/right pattern formation |
| Process | GO:0060973 | Cell migration involved in heart development |
| Process | GO:0060976 | Coronary vasculature development |
| Process | GO:0060977 | Coronary vasculature morphogenesis |
| Process | GO:0060979 | Vasculogenesis involved in coronary vascular morphogenesis |
| Process | GO:0060982 | Coronary artery morphogenesis |
| Process | GO:0061005 | Cell differentiation involved in kidney development |
| Process | GO:0061008 | Hepaticobiliary system development |
| Process | GO:0061061 | Muscle structure development |
| Process | GO:0061101 | Neuroendocrine cell differentiation |
| Process | GO:0061138 | Morphogenesis of a branching epithelium |
| Process | GO:0061311 | Cell surface receptor signaling pathway involved in heart development |
| Process | GO:0061314 | Notch signaling involved in heart development |
| Process | GO:0061326 | Renal tubule development |
| Process | GO:0061371 | Determination of heart left/right asymmetry |
| Process | GO:0061383 | Trabecula morphogenesis |
| Process | GO:0061384 | Heart trabecula morphogenesis |
| Process | GO:0061418 | Regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| Process | GO:0061419 | Positive regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| Process | GO:0061437 | Renal system vasculature development |
| Process | GO:0061440 | Kidney vasculature development |
| Process | GO:0061448 | Connective tissue development |
| Process | GO:0061458 | Reproductive system development |
| Process | GO:0061564 | Axon development |
| Process | GO:0062042 | Regulation of cardiac epithelial to mesenchymal transition |
| Process | GO:0062043 | Positive regulation of cardiac epithelial to mesenchymal transition |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070167 | Regulation of biomineral tissue development |
| Process | GO:0070168 | Negative regulation of biomineral tissue development |
| Process | GO:0070372 | Regulation of ERK1 and ERK2 cascade |
| Process | GO:0070374 | Positive regulation of ERK1 and ERK2 cascade |
| Process | GO:0070482 | Response to oxygen levels |
| Process | GO:0070727 | Cellular macromolecule localization |
| Process | GO:0070848 | Response to growth factor |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0070925 | Organelle assembly |
| Process | GO:0070986 | Left/right axis specification |
| Process | GO:0071216 | Cellular response to biotic stimulus |
| Process | GO:0071228 | Cellular response to tumor cell |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071345 | Cellular response to cytokine stimulus |
| Process | GO:0071363 | Cellular response to growth factor stimulus |
| Process | GO:0071371 | Cellular response to gonadotropin stimulus |
| Process | GO:0071372 | Cellular response to follicle-stimulating hormone stimulus |
| Process | GO:0071453 | Cellular response to oxygen levels |
| Process | GO:0071456 | Cellular response to hypoxia |
| Process | GO:0071495 | Cellular response to endogenous stimulus |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0072001 | Renal system development |
| Process | GO:0072006 | Nephron development |
| Process | GO:0072007 | Mesangial cell differentiation |
| Process | GO:0072008 | Glomerular mesangial cell differentiation |
| Process | GO:0072009 | Nephron epithelium development |
| Process | GO:0072012 | Glomerulus vasculature development |
| Process | GO:0072017 | Distal tubule development |
| Process | GO:0072044 | Collecting duct development |
| Process | GO:0072073 | Kidney epithelium development |
| Process | GO:0072080 | Nephron tubule development |
| Process | GO:0072091 | Regulation of stem cell proliferation |
| Process | GO:0072109 | Glomerular mesangium development |
| Process | GO:0072132 | Mesenchyme morphogenesis |
| Process | GO:0072143 | Mesangial cell development |
| Process | GO:0072144 | Glomerular mesangial cell development |
| Process | GO:0072148 | Epithelial cell fate commitment |
| Process | GO:0072359 | Circulatory system development |
| Process | GO:0072538 | T-helper 17 type immune response |
| Process | GO:0072594 | Establishment of protein localization to organelle |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0090049 | Regulation of cell migration involved in sprouting angiogenesis |
| Process | GO:0090051 | Negative regulation of cell migration involved in sprouting angiogenesis |
| Process | GO:0090090 | Negative regulation of canonical Wnt signaling pathway |
| Process | GO:0090092 | Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| Process | GO:0090100 | Positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| Process | GO:0090101 | Negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| Process | GO:0090257 | Regulation of muscle system process |
| Process | GO:0090287 | Regulation of cellular response to growth factor stimulus |
| Process | GO:0090288 | Negative regulation of cellular response to growth factor stimulus |
| Process | GO:0090304 | Nucleic acid metabolic process |
| Process | GO:0090596 | Sensory organ morphogenesis |
| Process | GO:0097084 | Vascular associated smooth muscle cell development |
| Process | GO:0097150 | Neuronal stem cell population maintenance |
| Process | GO:0097396 | Response to interleukin-17 |
| Process | GO:0097398 | Cellular response to interleukin-17 |
| Process | GO:0097400 | interleukin-17-mediated signaling pathway |
| Process | GO:0097659 | Nucleic acid-templated transcription |
| Process | GO:0098727 | Maintenance of cell number |
| Process | GO:0098773 | Skin epidermis development |
| Process | GO:0110149 | Regulation of biomineralization |
| Process | GO:0110150 | Negative regulation of biomineralization |
| Process | GO:0120031 | Plasma membrane bounded cell projection assembly |
| Process | GO:0120036 | Plasma membrane bounded cell projection organization |
| Process | GO:0120039 | Plasma membrane bounded cell projection morphogenesis |
| Process | GO:0120161 | Regulation of cold-induced thermogenesis |
| Process | GO:0120163 | Negative regulation of cold-induced thermogenesis |
| Process | GO:0140352 | Export from cell |
| Process | GO:0150063 | Visual system development |
| Process | GO:1901201 | Regulation of extracellular matrix assembly |
| Process | GO:1901360 | Organic cyclic compound metabolic process |
| Process | GO:1901362 | Organic cyclic compound biosynthetic process |
| Process | GO:1901522 | Positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| Process | GO:1901532 | Regulation of hematopoietic progenitor cell differentiation |
| Process | GO:1901533 | Negative regulation of hematopoietic progenitor cell differentiation |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901565 | Organonitrogen compound catabolic process |
| Process | GO:1901575 | Organic substance catabolic process |
| Process | GO:1901576 | Organic substance biosynthetic process |
| Process | GO:1901652 | Response to peptide |
| Process | GO:1901698 | Response to nitrogen compound |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1902263 | Apoptotic process involved in embryonic digit morphogenesis |
| Process | GO:1902337 | Regulation of apoptotic process involved in morphogenesis |
| Process | GO:1902339 | Positive regulation of apoptotic process involved in morphogenesis |
| Process | GO:1902531 | Regulation of intracellular signal transduction |
| Process | GO:1902533 | Positive regulation of intracellular signal transduction |
| Process | GO:1902679 | Negative regulation of RNA biosynthetic process |
| Process | GO:1902680 | Positive regulation of RNA biosynthetic process |
| Process | GO:1902692 | Regulation of neuroblast proliferation |
| Process | GO:1902742 | Apoptotic process involved in development |
| Process | GO:1903053 | Regulation of extracellular matrix organization |
| Process | GO:1903054 | Negative regulation of extracellular matrix organization |
| Process | GO:1903305 | Regulation of regulated secretory pathway |
| Process | GO:1903306 | Negative regulation of regulated secretory pathway |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:1903507 | Negative regulation of nucleic acid-templated transcription |
| Process | GO:1903508 | Positive regulation of nucleic acid-templated transcription |
| Process | GO:1903530 | Regulation of secretion by cell |
| Process | GO:1903531 | Negative regulation of secretion by cell |
| Process | GO:1903847 | Regulation of aorta morphogenesis |
| Process | GO:1903849 | Positive regulation of aorta morphogenesis |
| Process | GO:1903900 | Regulation of viral life cycle |
| Process | GO:1904238 | Pericyte cell differentiation |
| Process | GO:1904747 | Positive regulation of apoptotic process involved in development |
| Process | GO:1904748 | Regulation of apoptotic process involved in development |
| Process | GO:1904892 | Regulation of receptor signaling pathway via STAT |
| Process | GO:1904894 | Positive regulation of receptor signaling pathway via STAT |
| Process | GO:1905314 | Semi-lunar valve development |
| Process | GO:1905456 | Regulation of lymphoid progenitor cell differentiation |
| Process | GO:1905457 | Negative regulation of lymphoid progenitor cell differentiation |
| Process | GO:1905651 | Regulation of artery morphogenesis |
| Process | GO:1905653 | Positive regulation of artery morphogenesis |
| Process | GO:2000026 | Regulation of multicellular organismal development |
| Process | GO:2000047 | Regulation of cell-cell adhesion mediated by cadherin |
| Process | GO:2000048 | Negative regulation of cell-cell adhesion mediated by cadherin |
| Process | GO:2000136 | Regulation of cell proliferation involved in heart morphogenesis |
| Process | GO:2000137 | Negative regulation of cell proliferation involved in heart morphogenesis |
| Process | GO:2000145 | Regulation of cell motility |
| Process | GO:2000146 | Negative regulation of cell motility |
| Process | GO:2000147 | Positive regulation of cell motility |
| Process | GO:2000177 | Regulation of neural precursor cell proliferation |
| Process | GO:2000179 | Positive regulation of neural precursor cell proliferation |
| Process | GO:2000209 | Regulation of anoikis |
| Process | GO:2000241 | Regulation of reproductive process |
| Process | GO:2000736 | Regulation of stem cell differentiation |
| Process | GO:2000737 | Negative regulation of stem cell differentiation |
| Process | GO:2000811 | Negative regulation of anoikis |
| Process | GO:2000973 | Regulation of pro-B cell differentiation |
| Process | GO:2000974 | Negative regulation of pro-B cell differentiation |
| Process | GO:2000980 | Regulation of inner ear receptor cell differentiation |
| Process | GO:2000981 | Negative regulation of inner ear receptor cell differentiation |
| Process | GO:2001026 | Regulation of endothelial cell chemotaxis |
| Process | GO:2001027 | Negative regulation of endothelial cell chemotaxis |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0001669 | Acrosomal vesicle |
| Component | GO:0001726 | Ruffle |
| Component | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005783 | Endoplasmic reticulum |
| Component | GO:0005794 | Golgi apparatus |
| Component | GO:0005856 | Cytoskeleton |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005911 | Cell-cell junction |
| Component | GO:0005912 | Adherens junction |
| Component | GO:0009986 | Cell surface |
| Component | GO:0012505 | Endomembrane system |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0016324 | Apical plasma membrane |
| Component | GO:0030027 | Lamellipodium |
| Component | GO:0030054 | Cell junction |
| Component | GO:0030141 | Secretory granule |
| Component | GO:0030312 | External encapsulating structure |
| Component | GO:0031012 | Extracellular matrix |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031252 | Cell leading edge |
| Component | GO:0031410 | Cytoplasmic vesicle |
| Component | GO:0031982 | Vesicle |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0042995 | Cell projection |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0043235 | Receptor complex |
| Component | GO:0045177 | Apical part of cell |
| Component | GO:0070161 | Anchoring junction |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097708 | Intracellular vesicle |
| Component | GO:0098590 | Plasma membrane region |
| Component | GO:0099503 | Secretory vesicle |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
| Function | GO:0003676 | Nucleic acid binding |
| Function | GO:0003677 | DNA binding |
| Function | GO:0003682 | Chromatin binding |
| Function | GO:0003712 | Transcription coregulator activity |
| Function | GO:0003713 | Transcription coactivator activity |
| Function | GO:0004857 | Enzyme inhibitor activity |
| Function | GO:0004888 | Transmembrane signaling receptor activity |
| Function | GO:0005102 | Signaling receptor binding |
| Function | GO:0005112 | Notch binding |
| Function | GO:0005488 | Binding |
| Function | GO:0005509 | Calcium ion binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0019899 | Enzyme binding |
| Function | GO:0030234 | Enzyme regulator activity |
| Function | GO:0031490 | Chromatin DNA binding |
| Function | GO:0038023 | Signaling receptor activity |
| Function | GO:0042802 | Identical protein binding |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043169 | Cation binding |
| Function | GO:0046872 | Metal ion binding |
| Function | GO:0060089 | Molecular transducer activity |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0098772 | Molecular function regulator activity |
| Function | GO:0140110 | Transcription regulator activity |
| Function | GO:1901363 | Heterocyclic compound binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| WikiPathways | WP517 | Notch signaling pathway |
| KEGG | rno01522 | Endocrine resistance |
| KEGG | rno04330 | Notch signaling pathway |
| KEGG | rno04658 | Th1 and Th2 cell differentiation |
| KEGG | rno04919 | Thyroid hormone signaling pathway |
| KEGG | rno05020 | Prion disease |
| KEGG | rno05165 | Human papillomavirus infection |
| KEGG | rno05200 | Pathways in cancer |
| KEGG | rno05206 | MicroRNAs in cancer |
| KEGG | rno05224 | Breast cancer |
Expression profile of Notch1 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 8.3647145 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 8.530237249999999 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 8.318274 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 8.673945 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 8.619648999999999 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 8.2729855 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 8.5609968 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 8.6237405 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 8.02488165 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 8.1923052 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 8.395887250000001 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 8.28145185 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 8.60232575 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 8.1860037 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 8.56887185 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 8.410455 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 8.4908685 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 8.3577374 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 8.4043764 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 8.544832750000001 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 8.69661625 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 8.53006935 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 8.404066 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 8.35787 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.915127034 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.171379592 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.112069358 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.091541613 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.170996014 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.334585134 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 696.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 480.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 682.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 594.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 795.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 704.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 761.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1635.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 517.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 611.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 553.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 913.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 541.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 490.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 674.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 742.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.570262 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.587288 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.663948 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.627272 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.523531 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.536959 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 13.063 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 10.485 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 12.016 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 10.315 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 10.947 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 8.334387899 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 8.0945032125 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 8.173707988 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 449.9 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 403.9 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 457.45000000000005 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 498.25 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 424.20000000000005 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 491.95000000000005 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 601.0 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 432.3 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 560.55 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 571.6 | |
| GSM27494 | CTL_a (control, 1st replicate) | 452.5 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 419.55 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 512.15 | |
| GSM27497 | CTL_d (control, 4th replicate) | 424.55 | |
| GSM27498 | CTL_e (control, 5th replicate) | 439.15 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 502.84999999999997 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 256.3 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 519.1 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 419.29999999999995 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 814.9 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 473.5 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 383.7 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 377.4 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 473.09999999999997 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 428.9 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 776.35 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 738.9 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 945.25 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 786.5 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 779.15 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 247.85000000000002 |
| GSM30791 | baseline control 02 | male, 275-300g | 294.15 |
| GSM30792 | baseline control 03 | male, 275-300g | 281.5 |
| GSM30793 | baseline control 04 | male, 275-300g | 259.4 |
| GSM30794 | baseline control 05 | male, 275-300g | 333.9 |
| GSM30795 | baseline control 06 | male, 275-300g | 255.5 |
| GSM30796 | baseline control 07 | male, 275-300g | 244.35000000000002 |
| GSM30797 | baseline control 08 | male, 275-300g | 235.0 |
| GSM30798 | baseline control 09 | male, 275-300g | 280.1 |
| GSM30799 | pain 01 | 297.35 | |
| GSM30800 | pain 02 | 311.45000000000005 | |
| GSM30801 | pain 03 | 511.6 | |
| GSM30802 | pain 04 | 199.64999999999998 | |
| GSM30803 | pain 05 | 272.8 | |
| GSM30804 | FC 01 | 264.9 | |
| GSM30805 | FC 02 | 368.1 | |
| GSM30806 | FC 03 | 255.8 | |
| GSM30807 | FC 04 | 315.4 | |
| GSM30808 | FC 05 | 279.85 | |
| GSM30809 | IFC 01 | 213.75 | |
| GSM30810 | IFC 02 | 304.6 | |
| GSM30811 | IFC 03 | 350.35 | |
| GSM30812 | IFC 04 | 207.75 | |
| GSM30813 | IFC 05 | 249.29999999999998 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 232.45 |
| GSM99801 | isoflurane 02 | male, 275-300g | 262.35 |
| GSM99802 | isoflurane 03 | male, 275-300g | 257.1 |
| GSM99803 | isoflurane 04 | male, 275-300g | 344.0 |
| GSM99804 | isoflurane 05 | male, 275-300g | 257.75 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 76.20165 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 73.1123 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 66.83805000000001 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 60.3905 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 41.621 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 52.6191 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 68.38884999999999 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 65.86745 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 86.5672 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 8.35597 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 8.13034 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 7.43855 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 6.84876 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 8.54456 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 8.36613 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 8.46818 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 7.78583 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 7.58292 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 8.42671 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 7.18991 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 6.9628 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 8.02977 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 7.91623 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 7.61281 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 7.6435 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 7.453891 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 7.47589 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 7.534285 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 7.617973 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 7.380212 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 7.61426 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 7.624707 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 7.679761 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 7.577551 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 7.619776 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 7.490465 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 7.585035 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 7.535215 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 7.574554 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 7.619437 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 7.443514 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 7.436098 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 7.510856 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 7.612804 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 7.54013 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 7.39276 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 7.382896 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 7.361872 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 7.425536 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 7.473292 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 7.499297 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 7.610814 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 7.51462 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 7.632751 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 7.372137 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 7.643432 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 7.743534 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 7.216775 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 7.842764 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 7.702155 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 7.712281 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 7.520489 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 7.615186 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 7.906219 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 7.743877 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.261387 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.114736 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.205577 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.073877 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 7.082313 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 261.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 250.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 447.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 317.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 384.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 320.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 463.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 456.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 245.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 502.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 234.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 374.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 403.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 386.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 424.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 398.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 287.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 293.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 279.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 315.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 364.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 388.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 466.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 427.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 336.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 326.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 325.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 409.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 468.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 347.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 415.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 439.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 519.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 489.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 365.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 354.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 9.471172 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 8.948647 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 9.796889 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 11.383382 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | -0.0045 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | 0.114 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | -0.196 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | 0.145 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | -0.157 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | -0.017 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | 0.186 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | 0.166 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | 0.0786 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | 0.109 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | 0.329 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | 0.333 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 158.85 | |
| GSM5121 | Isoflurane single exposure control-2 | 131.35 | |
| GSM5122 | Isoflurane single exposure control-3 | 80.9 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 126.60000000000001 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 147.35 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 108.85 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 178.45 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 127.10000000000001 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 8.2682956655 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 8.3537551335 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 8.021200501500001 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 8.241556419 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 8.5951346535 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 7.768081949 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 6.7824152049999995 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 8.346836386 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 8.380339814 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 8.2439463915 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 7.706466278 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 8.654469618 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 8.0225882475 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 7.246201102 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 8.272395482 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 7.9254632449999995 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 6.676139577000001 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 7.7067337715 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 7.573613526000001 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 8.035955527 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 8.208343182 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 8.3813619455 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 8.0104896335 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 7.899281758000001 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.436636 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.045234 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.794395 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.167321 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.079035 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.462377 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.576231 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.395695 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.380244 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.411373 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.259082 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.397146 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.349682 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.622508 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.390798 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.418729 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.275265 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.412058 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.168484 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.003506 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.103447 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.145154 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.661791 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.509673 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 185.1106 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 162.3035 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 1372.3293426999999 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 1035.9972703 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 918.3736054000001 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 1035.7208231 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 1104.99400815 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 1083.31980095 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 983.8864868000001 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 1402.5331685 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 884.4402847499999 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 847.8350585 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 1283.1283729 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 1151.83601185 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 990.79018245 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 1417.020712 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 8.2682956655 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 8.3537551335 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 8.021200501500001 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 8.241556419 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 8.5951346535 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 7.768081949 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 6.7824152049999995 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 8.346836386 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 8.380339814 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 8.2439463915 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 7.706466278 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 8.654469618 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 8.0225882475 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 7.246201102 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 8.272395482 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 7.9254632449999995 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 6.676139577000001 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 7.7067337715 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 7.573613526000001 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 8.035955527 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 8.208343182 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 8.3813619455 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 8.0104896335 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 7.899281758000001 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 1372.3293426999999 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 1035.9972703 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 918.3736054000001 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 1035.7208231 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 1104.99400815 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 1083.31980095 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 983.8864868000001 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 1402.5331685 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 884.4402847499999 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 847.8350585 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 1283.1283729 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 1151.83601185 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 990.79018245 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 1417.020712 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 152.6 | |
| GSM5084 | Control 2 | 149.1 | |
| GSM5085 | Control 3 | 155.35 | |
| GSM5086 | Control 4 | 145.2 | |
| GSM5087 | Control 5 | 133.85 | |
| GSM5090 | Control 6 | 145.1 | |
| GSM5105 | Control 7 | 128.5 | |
| GSM5106 | Control 8 | 141.3 | |
| GSM5107 | Control 9 | 150.35000000000002 | |
| GSM5108 | Halothane 10 exposure-1 | 134.14999999999998 | |
| GSM5109 | Halothane 10 exposures-2 | 112.15 | |
| GSM5110 | Halothane 10 exposures-3 | 148.45 | |
| GSM5111 | Halothane 5 exposures-1 | 130.15 | |
| GSM5112 | Halothane 5 exposures-2 | 126.80000000000001 | |
| GSM5113 | Halothane 5 exposures-3 | 141.8 | |
| GSM5114 | Isoflurane 10 exposures-1 | 115.75 | |
| GSM5115 | Isoflurane 10 exposures-2 | 137.35 | |
| GSM5116 | Isoflurane 10 exposures-3 | 132.15 | |
| GSM5117 | Isoflurane 5 exposures-1 | 149.8 | |
| GSM5118 | Isoflurane 5 exposures-2 | 132.39999999999998 | |
| GSM5119 | Isoflurane 5 exposures-3 | 161.75 | |
| GSM11379 | Control 10 | 157.45 | |
| GSM11380 | Control 11 | 167.89999999999998 | |
| GSM11381 | Control 12 | 156.55 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 17.1738055 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 26.9195 |
